Corporate Communications Intern – Competitive Intelligence & Strategic Planning
Zoetis
Summary
The Corporate Communications Intern will support the Corporate Communications team in competitive intelligence and issues management, strategic planning, financial and corporate narrative, and issues management.
Job description
Internship Summary
The Corporate Communications Intern will support the Corporate Communications team in competitive intelligence and issues management, strategic planning, financial and corporate narrative, and issues management.
Competitive Intelligence
- Monitor social and digital media conversations about Zoetis and competitors for reputational risks or issues management.
- Identify and track industry trends, including shifts in conversation, emerging narratives, and issues that may warrant further attention.
- Analyze and report on listening data.
Quarterly Earnings Communications
- Support content development of internal and external social channels.
- Assist with press release and slide development.
- External monitoring of key and trending topics.
- Support broader team projects as needed, such as communications planning, corporate materials, earnings support, or issues tracking.
Additional Communications Support
- Research and provide perspective on white space opportunities that could shape the 2028 Corporate Communications plan.
- Support drafting and updating key corporate materials including fact sheets, talking points, and executive bios.
- Shadow and support real-time issues tracking and response documentation.
Requirements
- Relevant course work, projects, or community organization involvement
- Proficient in Microsoft Excel and PowerPoint
- Quantitative and qualitative data analysis
- Able to clearly communicate the meaning of data
- Strong written communication skills of business topics
- Strategic and analytical thinker
Company overview
Zoetis is a global leader in animal health, dedicated to advancing care for animals and the people who care for them. Originally established as the animal health division of Pfizer, Zoetis became an independent public company in 2013. The company develops, manufactures, and commercializes a comprehensive portfolio of medicines, vaccines, diagnostics, and other health products for both livestock and companion animals. With operations in more than 100 countries, Zoetis serves veterinarians, livestock producers, and pet owners worldwide. The company's product portfolio includes anti-infectives, vaccines, parasiticides, dermatology products, and other therapeutic solutions. Zoetis invests significantly in research and development to address unmet medical needs in animal health, focusing on areas such as pain management, infectious diseases, and chronic conditions. The company's commitment to innovation and quality has established it as a trusted partner in the animal health industry, contributing to food security and the well-being of companion animals globally.